FDA: Abbott Recall of Some Ellipse Defibrillators Categorized as Class I

Date : 08/05/2019 @ 11:41PM
Source : Dow Jones News
Stock : Abbott Laboratories (ABT)
Quote : 85.71  1.59 (1.89%) @ 1:00AM
After Hours
Last Trade
Last $ 85.71 ◊ 0.00 (0.00%)

FDA: Abbott Recall of Some Ellipse Defibrillators Categorized as Class I

Abbott Laboratories (NYSE:ABT)
Historical Stock Chart

6 Months : From May 2019 to Nov 2019

Click Here for more Abbott Laboratories Charts.
   By Josh Beckerman 

The U.S. Food and Drug Administration has identified an Abbott Laboratories (ABT) June recall of certain Ellipse Implantable Cardioverter Defibrillators as a Class I recall.

The FDA said 108 devices were recalled in the U.S. because of a faulty manufacturing process that caused some wires to be partially exposed.

Abbott isn't aware of any reports of device failure in implanted devices, the FDA said.


Write to Josh Beckerman at josh.beckerman@wsj.com


(END) Dow Jones Newswires

August 05, 2019 19:26 ET (23:26 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest ABT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.